Article Data

  • Views 204
  • Dowloads 118

Original Research

Open Access

Different types of hysterectomy in the radio-surgical treatment of early cervical cancer (FIGO lb-Ila)

  • P. Zola1,*,
  • A. Ferrero1
  • L. Fuso1
  • M. E. Jacomuzzi1
  • A. Magistris1
  • P. Spanu1
  • S. Mazzola1
  • G. Sinistrero2
  • P. Sismondi1

1Gynecological Oncology Department, University of Turin, Mauriziano Umberto I Hospital Institute for Research and Treatment of Cancer (IRCC) Candiolo, Italy

2Arturo Pinna Pintor Foundation, Turin, Italy

DOI: 10.12892/ejgo200203236 Vol.23,Issue 3,May 2002 pp.236-242

Published: 10 May 2002

*Corresponding Author(s): P. Zola E-mail:

Abstract

Purpose of investigation: Surgery and radiotherapy achieved equivalent results for FIGO stages Ib-IIa invasive cervical carcinoma. The integration of radiotherapy and surgery provided the same results for a selected series of patients without increasing the rate of complications. The aim of the study was to verify if, applying a radio-surgical protocol, the reduction of the surgery extension on the parametrium in one of two consecutive series might achieve the same results in terms of survival and recurrence rates with fewer complications.

Material and methods: We analysed actuarial survival (with >10-year follow-up), local control rates and morbidity of 390 patients who had different the kinds of surgery applied in the radio-surgical treatment protocol: Protocol A: brachytherapy plus type III radical hysterectomy vs Protocol B: brachytherapy plus type II radical hysterectomy. Patients were all included in an analysis of complications according to the French-Italian glossary.

Results: Analyses showed no differences in terms of survival, patterns of recurrences and onset time within the two protocols. Urinary complications were more frequent and severe in protocol A vs protocol B (G2: 26.5% vs. 6.1%; G3: 5.3% vs. 3.6%).

Conclusion: Our study pointed out that the reduction of the surgery extension allowed the same overall survival and relapses with fewer complications particularly in terms of grade of severity.

Keywords

Cervical cancer; Surgery; Radiotherapy; Glossary of complications


Cite and Share

P. Zola,A. Ferrero,L. Fuso,M. E. Jacomuzzi,A. Magistris,P. Spanu,S. Mazzola,G. Sinistrero,P. Sismondi. Different types of hysterectomy in the radio-surgical treatment of early cervical cancer (FIGO lb-Ila) . European Journal of Gynaecological Oncology. 2002. 23(3);236-242.

References

[1] Brundschwig A.: "The surgical treatment of cancer of the cervix: stage I and II". A.J.R., 1968, 102, 147.

[2] Chassagne D, Si、mondi P. Horiot J. C. Sinistrero G, Bey P., Zola P.et al.: "A glossary for reporting complications of treatment in gynecological cancers". Radiother. Oneal., 1993, 26 (3), 195.

[3] Currie W. C.: "Operative treatment of carcinoma of the cervix". J. Obstet. Gynecol., Br. Commonwlth., 1971, 78, 385.

[4] Morgan L. S. and Nelson J. M.: "Jr. Surgical treatment of early cervical cancer". Se min. Oneal., 1982, 9 (3), 312.

[5] Park R. C., Patow W. E., Rogers R. E. and Zimmerman E. A.: "Treatment of stage I carcinoma of the cervix". Obstet. Gynecol., 1973, 41 (1), 117.

[6] Colombo A., Landoni F., Maneo A., Zanetta G., Nava S., Tanc1111 G.: "Neoadjuvant chemotherapy to rad风tion and concurrent chemoradiation for locallyadvanced squamous cell carcinoma of the cervix: a review of the recentliterature". Tumori, 1998, 84 (2), 229.

[7] Adcock L. L., Potish R. A., Julian T. M.. Okagaki M. D., Prem K A., Twiggs L. B. et al.: "Carcinoma of the cervix. FIGO Stage Ib: treatment failures". Gvnecol. Oncol. 1984, 18 (2). 218.

[8] Combes P. F., Daly N. J., Horiot J. C. et al.: "Results of radiotherapy alone in 581 patients with 、tage II carcinoma of the uterine cervix". Int. J. Radial. Oneal. Biol. Phys., 1985, ff (4), 463.

[9] arnpolis S., Andras J., F letcher J. H.: "Analysis of sites and causes of failure of irradiaon in invasive squamous eel carcinoma of the intact uterine cerix". Radiology, 1975, 115.

[10] Perez C. A., Grigsby P. W., Camel H. M., Galakatos A. E., Mutch D.. Lockett M.A.: "Irradiation alone or combined with surgery in stage TB, TIA, and JIB carcinoma of uterine cervix: update of a non-randomised comparison". Int. J. Radial. Oneal. Biol. Phys., 1995. 31 (4), 703.

[11] Watherspoon B. J., Marks R. D., More T. N., Underwood T. B. and Wilson W.: "The role of radiation therapy in the manegement of patiens with Ib carcinoma of the cervix". Int. J. Radiat. Oncol. Biol. Phys.. 1979, 5 (10), 1757.

[12] Sardi J., Sananes C., Giaroli A., Maya G., Di Paola G.: "Neoadjuvant chemotherapy in locally advanced carcinoma of the cervixuteri". Gynecol. Oncol., 1990, 38 (3). 486.

[13] Kim D. S., Moon H.. Kim K. T., Hwang Y. Y., Cho S. H.. Kim S. R.: "Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages lb and TI with bulky tumor". Gynecol. Oncol., 1989, 33 (2), 225.

[14] Dottino P. R., Plaxe S. C., Beddoe A. M., Johnston C., Cohen C J.: "Induction chemotherapy followed by radical surgery in cervical cancer". Gynecol. Oncol., 199 I. 40 (1), 7.

[15] Giaroli A., Sananes C., Sardi J.E., Maya A. G., Bastardas M. L., Snaidas L. et al.: "Lymph node metastases in carcinoma of the cervix uteri: re、pon、e to ueoadjuvant chemotherapy and its impact on survival". Gynecol. Oncol., 1990, 39 (1I), 34.

[16] Benedetti-Panici P., Greggi S., Scambia G., Amoroso M., Salerno M. G., Maneschi F. et al.: "Long-term survival following neoadjuvant chemotherapy and radical surgery inlocally advanced cervical cancer". Eur. J. Cancer, 1998, 34 (3), 341.

[17] Katsaros D., Zola P., Sinistrero G. et al.: "Weekly cisplatin induction chemotherapy in high-risk cervical cancer patients with bulky tumor: a phase II study". Int. Journal of oncolo g y , 1995, 6 (1), 1033.

[18] Keys H. M.. Bundy B. N.. Stehman F. B., Muderspach L. I., Chafe W. E.. Suggs C. L. 3''et al.: "Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma". N. Engl. J. Med., 1999, 340 (15), 1154.

[19] Morris M., Eifel P. J., Lu J., Grigsby P. W., Leven back C., Stevens R. E. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer". N. Engl. J. Med., 1999, 340 (15), 1137.

[20] Peters W. A 3'', Liu P. Y., Barrett R. J. 2"', Stock R. J., Monk B. J., Berek J. S. et al.: "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-riskearly-stage cancer of the cervix". J. Clin.Oncol., 2000, 18 (8), 1606.

[21] Rose P. G、Bundy B. N., Watkins E. B.. Thigpen J. T., Deppe G., Maiman M. A. et al.: "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer". N. EnglJ. Med., 1999, 340 (15)., 1144.

[22] Whitney C. W., Sause W., Bundy B. N., Malfetano J. H., Han111-gan E. V., Fowler W. C. et al.: "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as anadjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study". J. Clin. Oncol.,1999, 17 (5)., 1339.

[23] Sinistrero G., Sismondi P., Zola P.: "Results of treatment of utenne cervix cancer by radiotherapy". Radiother. Oncol., 1988, 13 (4), 257.

[24] Piver M. S., Rutledge F., Smith J.P.: "Five classes of extended hysterectomy for women with cervical cancer". Obstet. Gynecol., 1974, 44 (2), 265.

[25] Durrance F. Y., Fletcher G. H., Rutledge F. N.: "Analysis of central recurret disease in stage I and II squamous cell carcinomas of the cervix on intact uteru". Am. J. Roentgenol. Rad. Ther. Nucl. Med., 1969, 106, 831.

[26] Eifel P. J., Thoms W. W., Smith T. L., Morris M., Oswald M. J.: 'The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone". Int. J. Radiat. Oneal. Biol. Phys., 1994, 28 (1), 113.

[27] Einhorn N., Bygdeman M., Sjoberg B.: "Combined radiation and surgical treatment for carcinoma of the uterine cervix". Cancer, 1980, 45 (4), 720.

[28] Gallion H. H., van Nagell J. R., Donaldson E. S., Hanson M. B., Powell D. E., Maruyama Y. et al.: "Combined radiation therapy and extra-fascia] hysterectomy in the treatment of stage 1B barrelshaped cervical cancer". Cancer, 1985, 56 (2), 262.

[29] Gerbaulet A., Haie C., Michel G., Castainge G., Prade M., Kunkler I. et al.: "Combined radio-surgical treatment in early invasive cervix carcinoma according to prognostic factors. Experience of the Gustave-Roussy Institute". Eur. J. Gynaecol. Oncol., 1992, 13 (3), 256.

[30] Landoni F., Maneo A., Cormio G., Perego P., Milani R., Carnso O, et al.: "Class II versus class III radical hysterectomy in stage IBIIA cervical cancer: A prospective randomized study". Gynecol. Oncol., 2001, 80 (1), 3.

[31] Gerbaulet A. L., Kunkler I. H., Kerr G. R.. Haie C., Michel G., Prade M. et al.: "Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix the Villejuif experience, I 975-1984". Radiothe1: Oncol., 1992, 23(2), 66 (Review)

[32] Larson D. M., Stringer C. A., Copeland L. J., Gershenson D. M., Malone J. M. Jr., Rutledge F. N.: "Stage 1B cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapy". Obstet. Gynecol., 1987, 69 /3Ptl), 378.

[33] Jacobs A. J., Perez C. A., Camel H. M., Kao M. S.: "Complications in patients receiving both irradiation and radical hysterectomyfor carcinoma of the uterine cervix". Gynecol. Oneal., 1985, 22 (3), 273.

[34] Mangioni C., Landoni F., Colombo A., Marsiglia H., Maggioni A., Sasso G.: "Concurrent platinum-based chemo- and radiotherapy for locally advanced cervicalcancer: a new gold-standard treatment' 1". Ann. Oneal., 1999, 10 (6), 647.

[35] Eifel P. J.: "Chemoradiation for carcinoma of the cervix: advances and opportunities". Radiat. Res., 2000, 154 (3), 229 (Review)

[36] Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P. et al.: "Randomised study of radical surgery versus radiotherapy for stage lb-llacervical cancer". Lancet. , 1997, 2 3 , 350/9077), 535.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top